Get the Stockscreener App
22.02
2.10%
0.4598
Fulgent Genetics Inc stock is traded at $22.02, with a volume of 57,648.
It is up +2.10% in the last 24 hours and up +5.38% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$21.56
Open:
$21.37
24h Volume:
57,648
Relative Volume:
0.42
Market Cap:
$665.32M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-13.43
EPS:
-1.64
Net Cash Flow:
$11.70M
1W Performance:
+9.90%
1M Performance:
+5.38%
6M Performance:
+2.39%
1Y Performance:
-18.29%
1-Day Range:
$21.26
$22.06
1-Week Range:
$19.76
$22.05
52-Week Range:
$18.76
$30.68
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-18-22 | Initiated | Raymond James | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Feb-04-22 | Resumed | Piper Sandler | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Underperform |
| Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-20-20 | Initiated | Oppenheimer | Outperform |
| May-29-20 | Initiated | BTIG Research | Buy |
| Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Fulgent to Participate in Upcoming Conferences - StockTitan
Creative Planning Buys 8,075 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Up 5.6% in October - Defense World
Fulgent Genetics secures $99M VA contract for genetic testing By Investing.com - Investing.com Australia
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Positive week for Fulgent Genetics, Inc. (NASDAQ:FLGT) institutional investors who lost 20% over the past year - Simply Wall St
Fulgent Genetics (FLGT) Scheduled to Post Quarterly Earnings on Friday - Defense World
Fulgent Genetics secures $99M VA contract for genetic testing - Investing.com India
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1 - BioSpace
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans - Marketscreener.com
Fulgent Genetics (NASDAQ:FLGT) Reaches New 52-Week LowWhat's Next? - MarketBeat
Fulgent Genetics stock hits 52-week low at $18.9 amid market shifts - Investing.com
(FLGT) On The My Stocks Page - Stock Traders Daily
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024 - BioSpace
Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Drops By 11.5% - MarketBeat
Marquette Asset Management LLC Grows Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Renaissance Technologies LLC Has $861,000 Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Millennium Management LLC Has $18.81 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Bought by Algert Global LLC - Defense World
Dimensional Fund Advisors LP Has $23.86 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
American Century Companies Inc. Has $698,000 Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Dark Forest Capital Management LP - Defense World
Canada Pension Plan Investment Board Takes Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Where are the Opportunities in (FLGT) - Stock Traders Daily
Caxton Associates LP Acquires Shares of 25,095 Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Investors push Fulgent Genetics (NASDAQ:FLGT) 8.7% lower this week, company's increasing losses might be to blame - Simply Wall St
Fulgent Genetics: An NCAV Pick With Profit And Growth Potential (NASDAQ:FLGT) - Seeking Alpha
Federated Hermes Inc. Buys 3,374 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Texas Permanent School Fund Corp Buys 5,080 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Stake Raised by Rhumbline Advisers - Defense World
Divisadero Street Capital Management LP Has $9.91 Million Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Divisadero Street Capital Management LP Acquires 160,212 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107% - Yahoo Finance
Acadian Asset Management LLC Has $1.23 Million Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Acadian Asset Management LLC Acquires 53,680 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Bank of New York Mellon Corp Acquires 55,020 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Bank of New York Mellon Corp Has $3.95 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Quest Partners LLC Grows Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Principal Financial Group Inc. Sells 4,347 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics: Core Growth Re-Acceleration As Critical Catalyst (NASDAQ:FLGT) - Seeking Alpha
Acuitas Investments LLC Makes New $962,000 Investment in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
nVerses Capital LLC Purchases New Shares in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Signaturefd LLC Increases Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics CFO sells shares worth over $16,000 By Investing.com - Investing.com Australia
Fulgent Genetics CEO sells shares worth over $52k By Investing.com - Investing.com Australia
Fulgent Genetics executive sells shares worth over $16k By Investing.com - Investing.com South Africa
Fulgent Genetics exec sells shares worth over $12k - Investing.com India
Fulgent Genetics CEO sells shares worth over $52k - Investing.com India
Hanlin Gao Sells 563 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) Stock - MarketBeat
Fulgent Genetics exec sells shares worth over $12k By Investing.com - Investing.com Canada
Fulgent Genetics executive sells shares worth over $16k - Investing.com India
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.65%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):